Company intelligence / Profile preview

Nicoya Therapeutics

Kitchener, Ontario, Canada

Ownership: Private
Employees: ~100
Development stage: Other

Overview

Nicoya is a biotechnology tools company that develops and commercializes next-generation benchtop instruments for label-free biomolecular interaction analysis using surface plasmon resonance, as well as additional biophysical characterization instruments via its Applied Photophysics acquisition. Its technologies are widely used in drug discovery and biologics development, but it does not develop therapeutics itself.

Industry: Non-Drug Biotech

Partnerships

Protein Stable (JV with Fluorescence Innovations)Academic and AI/drug discovery collaborations (names not specified)

Beyond the preview

Go deeper on Nicoya Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nicoya Therapeutics.

Explore the full profile